#BEGIN_DRUGCARD DB02731

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
148-61-8

# ChEBI_ID:
33214

# Chemical_Formula:
C9H10HgO2S

# Chemical_IUPAC_Name:
2-[(ethylmercurio)sulfanyl]benzoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Antiseptic Agents
Preservatives, Pharmaceutical

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Thimerosal

# HET_ID:
EMT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C7H6O2S.C2H5.Hg/c8-7(9)5-3-1-2-4-6(5)10;1-2;/h1-4,10H,(H,8,9);1H2,2H3;/q;;+1/p-1

# InChI_Key:
InChIKey=HXQVQGWHFRNKMS-UHFFFAOYSA-M

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2731

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
382.83

# Molecular_Weight_Mono:
384.010775858

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KDG

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.15

# Predicted_LogS:
-1.9

# Predicted_Water_Solubility:
4.63e+00 g/l

# Primary_Accession_No:
DB02731

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
67361

# PubChem_Substance_ID:
46506518

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01342

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC[Hg]SC1=CC=CC=C1C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
2-(ethylmercuri-thio)-benzoic acid
EMT
[(o-carboxyphenyl)thio]ethylmercury
ethylmercurithiosalicylic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:26 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Mitochondrion

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
OXCT1

# Drug_Target_1_GenBank_ID_Gene:
U62961

# Drug_Target_1_GenBank_ID_Protein:
1519052

# Drug_Target_1_GeneCard_ID:
OXCT1

# Drug_Target_1_Gene_Name:
OXCT1

# Drug_Target_1_Gene_Sequence:
>1563 bp
ATGGCGGCTCTCAAACTCCTCTCCTCCGGGCTTCGGCTCTGCGCCTCTGCCCGCGGATCT
GGGGCAACCTGGTACAAGGGATGTGTTTGTTCCTTTTCCACCAGTGCTCATCGCCATACC
AAGTTTTATACAGATCCAGTAGAAGCTGTAAAAGACATCCCTGATGGTGCCACGGTTTTG
GTTGGTGGTTTTGGGCTATGTGGAATTCCAGAGAATCTTATAGATGCTTTACTGAAAACT
GGAGTAAAAGGACTAACTGCAGTCAGCAACAATGCAGGGGTTGACAATTTTGGTTTGGGG
CTTTTGCTTCGGTCGAAGCAGATAAAACGCATGGTCTCTTCATATGTGGGAGAAAATGCA
GAATTTGAACGACAGTACTTATCTGGTGAATTAGAAGTGGAGCTGACACCACAGGGCACA
CTTGCAGAGAGGATCCGTGCAGGCGGGGCTGGAGTTCCTGCATTTTACACCCCAACAGGG
TATGGGACCCTGGTACAAGAAGGAGGATCGCCCATCAAATACAACAAAGATGGCAGTGTT
GCCATTGCCAGTAAGCCAAGAGAGGTGAGGGAGTTCAATGGTCAGCACTTTATTTTGGAG
GAAGCAATTACAGGGGATTTTGCTTTGGTGAAAGCCTGGAAGGCGGACCGAGCAGGAAAC
GTGATTTTCAGGAAAAGTGCAAGGAATTTCAACTTGCCAATGTGCAAAGCTGCAGAAACC
ACAGTGGTAGAGGTTGAAGAAATTGTGGATATTGGAGCATTTGCTCCAGAAGACATCCAT
ATTCCTCAGATTTATGTACATCGCCTTATAAAGGGAGAAAAATATGAGAAAAGAATTGAG
CGTTTATCAATCCGGAAAGAGGGAGATGGGGAAGCCAAATCTGCTAAACCTGGAGATGAC
GTAAGGGAACGAATCATCAAGAGGGCCGCTCTTGAGTTTGAGGATGGCATGTATGCTAAT
TTGGGCATAGGAATCCCTCTCCTGGCCAGCAATTTTATCAGCCCAAATATAACTGTTCAT
CTTCAAAGTGAAAATGGAGTTCTGGGTTTGGGTCCATATCCACGACAACATGAAGCTGAT
GCAGATCTCATCAATGCAGGCAAGGAAACAGTTACTATTCTTCCAGGAGCCTCTTTTTTC
TCCAGCGATGAATCATTTGCAATGATTAGAGGTGGACACGTCGATCTGACAATGCTAGGA
GCGATGCAGGTTTCCAAATATGGTGACCTGGCTAACTGGATGATACCTGGGAAGATGGTG
AAAGGAATGGGAGGTGCTATGGATTTAGTGTCCAGTGCGAAAACCAAAGTGGTGGTCACC
ATGGAGCATTCTGCAAAGGGAAATGCACATAAAATCATGGAGAAATGTACATTACCATTG
ACTGGAAAGCAATGTGTCAACCGCATTATTACTGAAAAGGCTGTGTTTGATGTGGACAAG
AAGAAAGGGTTGACTCTGATTGAGCTCTGGGAAGGCCTGACAGTGGATGACGTACAAAAG
AGTACTGGGTGTGATTTTGCAGTTTCACCAAAACTCATGCCAATGCAGCAGATCGCAAAT
TGA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
10964512	Fukao T, Mitchell GA, Song XQ, Nakamura H, Kassovska-Bratinova S, Orii KE, Wraith JE, Besley G, Wanders RJ, Niezen-Koning KE, Berry GT, Palmieri M, Kondo N: Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics. 2000 Sep 1;68(2):144-51.
8751852	Kassovska-Bratinova S, Fukao T, Song XQ, Duncan AM, Chen HS, Robert MF, Perez-Cerda C, Ugarte M, Chartrand C, Vobecky S, Kondo N, Mitchell GA: Succinyl CoA: 3-oxoacid CoA transferase (SCOT): human cDNA cloning, human chromosomal mapping to 5p13, and mutation detection in a SCOT-deficient patient. Am J Hum Genet. 1996 Sep;59(3):519-28.
9671268	Song XQ, Fukao T, Watanabe H, Shintaku H, Hirayama K, Kassovska-Bratinova S, Kondo N, Mitchell GA: Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency: two pathogenic mutations, V133E and C456F, in Japanese siblings. Hum Mutat. 1998;12(2):83-8.

# Drug_Target_1_HGNC_ID:
HGNC:8527

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4003

# Drug_Target_1_Locus:
5p13.1

# Drug_Target_1_Molecular_Weight:
56158

# Drug_Target_1_Name:
Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial

# Drug_Target_1_Number_of_Residues:
520

# Drug_Target_1_PDB_ID:
1OOY

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01144	CoA_trans

# Drug_Target_1_Protein_Sequence:
>Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial
MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVL
VGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENA
EFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSV
AIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAET
TVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDD
VRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEAD
ADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMV
KGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDK
KKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN

# Drug_Target_1_Reaction:
succinyl-CoA + a 3-oxo acid = succinate + a 3-oxoacyl-CoA

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Key enzyme for ketone body catabolism. Transfers the CoA moiety from succinate to acetoacetate. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate

# Drug_Target_1_SwissProt_ID:
P55809

# Drug_Target_1_SwissProt_Name:
SCOT1_HUMAN

# Drug_Target_1_Synonyms:
EC 2.8.3.5
Scot-S
Somatic-type succinyl CoA:3-oxoacid CoA- transferase
Succinyl-CoA:3-ketoacid-coenzyme A transferase 1, mitochondrial precursor

# Drug_Target_1_Theoretical_pI:
7.52

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE000512

# Drug_Target_2_GenBank_ID_Protein:
4980484

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
TM_1359

# Drug_Target_2_Gene_Sequence:
>126 bp
ATGGTTTATGGAAAGGAAGGATATGGAAGGTCAAAAAACATCTTGCTTTCAGAGTGTGTT
TGTGGTATAATTTCTCTTGAACTCAACGGGTTTCAATACTTCCTTAGAGGTATGGAAACT
CTGTGA

# Drug_Target_2_General_Function:
Signal transduction mechanisms

# Drug_Target_2_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6563

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
88728.3

# Drug_Target_2_Name:
Sensor protein

# Drug_Target_2_Number_of_Residues:
755

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00512	HisKA
PF00989	PAS
PF02518	HATPase_c

# Drug_Target_2_Protein_Sequence:
>Sensor protein
MVPERLKQIKGIRILESEDEIPQEGFTCRFGKHTVVANDEESFEIVRLYKRLTVYELLLS
LVDSICVHPKEEALRFSLKKVREFLDAEEVYLIEGDASYSSKGEKLSIDEIKKKHPGASV
REWRNKLHLVVVREGAFDEEEEVLCTKLLEFIGNVSEKLWRLKEEVQKLKKSYEEQLKVS
EIQKEHIKKMRIIYYVSQAMRSVYDPNNLYRVILLSLVSERGFNFDRAVLLKKDEGTGSL
MVVSAVGGDTLQEHEELKRYLRKRTLRYTDLVQFLREEALTFSFETKFNEKIRGKRFYYR
EHPIFERVVLRKSIVRTSRETLEKIRYEIEDVISILENDEFIVFPLVGRWDTLGVVVVDN
KFSKKEVTDLDLDVLKLFSESAGLALENAYNYENLRKKTLDLQRQNELVEHLRNFSESIL
ESLETAIITLSKDGRITEWNKKAEQLFGLKKENVLGRRLKDLPDFEEIGSVAESVFENKE
PVFLNFYKFGERYFNIRFSPFRNAKTQLLEGVIITIDDVTELYKYEEERKRRERLSILGE
MTARVAHEIRNPITIIGGFIMRMKKHLDDPETLKKYINIITNELSRLETIVKEILEYSKE
RQVLEFTEFNLNELIREVYVLFEEKIRKMNIDFCFETDNEDLRVEADRTRIKQVLINLVQ
NAIEATGENGKIKITSEDMYTKVRVSVWNSGPPIPEELKEKIFSPFFTTKTQGTGLGLSI
CRKIIEDEHGGKIWTENRENGVVFIFEIPKTPEKR

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + protein L-histidine = ADP + protein N- phospho-L-histidine

# Drug_Target_2_SwissProt_ID:
Q9X180

# Drug_Target_2_SwissProt_Name:
Q9X180_THEMA

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
6.11

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02731
